MECOM and acute myeloid leukemia: Although most patients with 3q26 rearrangements (inv(3)(q21q26.2)/t(3,3)(q21;q26.2) overexpress EVI1 (EVI1+), its level, through unknown mechanisms, is also elevated in about 10% of AML patients with no 3q aberrations [18].